{
    "nctId": "NCT02581670",
    "briefTitle": "Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer",
    "officialTitle": "Prospective Non-randomized Phase II Study on Stereotactic Body Radiation Therapy for Medically Inoperable Lung and Liver Oligometastases From Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Metastasis to Liver, Metastasis to Lung",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 65,
    "primaryOutcomeMeasure": "Toxicity in oligometastatic breast cancer patients monitoring using CTCAE v.4",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients aged \\>18 years with ECOG 0-2\n* Diagnosis of Breast Cancer\n* DFI (Disease-free interval) \\> 1 year\n* No extrapulmonary and/or extrahepatic disease or other metastatic sites stable or responding after chemotherapy\n* No life threatening conditions\n* Lung and liver lesions \\< 5 (with maximum diameter \\< 5 cm)\n* Chemotherapy completed at least 3 weeks before treatment\n* Chemotherapy started at least 2 weeks after treatment allowed\n* Systemic therapies other than chemotherapy allowed (i.e hormonal therapies and/or immunotherapy)\n* Written informed consent\n\nExclusion Criteria:\n\n* ECOG \\> 2\n* Pregnant women\n* Patients with inability to consent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}